Jim Cramer Blog

Although Cramer prefers big farms to big Pharma, he devoted an entire program to discussing drug companies people keep asking him about, because "most of you are going to do whatever the heck you want, so I'm here to minimize the damage." The sector suffers from the ailments of patent expiration, generic competition, FDA wavering, slow growth and lawsuits, but some drug companies are worse than others. At the bottom of the barrel sits JNJ and PFE, which is "the worst of both worlds .... Patent expiration, weak pipeline." Cramer says "Buffett's wrong" about JNJ with it patent protection problems and no new big drugs on the horizon.